OpenURL Connection Search

Select item for more details and to access through your institution.

Targeted therapies for patients with advanced colorectal cancer: focus on cetuximab.
Published in:
Targeted Oncology, 2006, v. 1, n. 1, p. 2, doi. 10.1007/s11523-005-0001-2
By:
- Cutsem, E.;
- Labianca, R.;
- Cognetti, F.;
- Tabernero, J.
Publication type:
Article
Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non-Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Receptor Mutations.
Published in:
2011
By:
- Farina G;
- Longo F;
- Martelli O;
- Pavese I;
- Mancuso A;
- Moscetti L;
- Labianca R;
- Bertolini A;
- Cortesi E;
- Farris A;
- Fagnani D;
- Locatelli MC;
- Valmadre G;
- Ardizzoia A;
- Tomirotti M;
- Rulli E;
- Garassino MC;
- Scanni A
Publication type:
Journal Article
Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
Published in:
2008
By:
- Di Costanzo F;
- Gasperoni S;
- Manzione L;
- Bisagni G;
- Labianca R;
- Bravi S;
- Cortesi E;
- Carlini P;
- Bracci R;
- Tomao S;
- Messerini L;
- Arcangeli A;
- Torri V;
- Bilancia D;
- Floriani I;
- Tonato M;
- Dinota A;
- Strafiuso G;
- Corgna E;
- Porrozzi S
Publication type:
Journal Article
Re: adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Published in:
2007
By:
- Fazio N;
- Biffi R;
- Curigliano G;
- Lorizzo K;
- Zampino MG;
- De Braud F;
- Chiappa A;
- Roth A;
- Goldhirsch A;
- Cascinu S;
- Scartozzi M;
- Barone C;
- Labianca R;
- Santoro A;
- Carnaghi C;
- Beretta G;
- Catalano V;
- Barni S;
- Frontini L
Publication type:
Journal Article
GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma--long term results and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione Interventi in Oncologia. Studio Italiano Terapia Adiuvante Colon.
Published in:
1998
By:
- Zaniboni, A;
- Labianca, R;
- Marsoni, S;
- Torri, V;
- Mosconi, P;
- Grilli, R;
- Apolone, G;
- Cifani, S;
- Tinazzi, A
Publication type:
journal article
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report.
Published in:
1995
By:
- Zaniboni, Alberto;
- Barni, Sandro;
- Labianca, Roberto;
- Marini, Giovanni;
- Pancera, Gianfranco;
- Giaccon, Gianfranco;
- Piazza, Elena;
- Signaroldi, Alfredo;
- Legnani, Walter;
- Luporini, Gino;
- Zaniboni, A;
- Barni, S;
- Labianca, R;
- Marini, G;
- Pancera, G;
- Giaccon, G;
- Piazza, E;
- Signaroldi, A;
- Legnani, W;
- Luporini, G
Publication type:
journal article
Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine.
Published in:
1994
By:
- Brambilla, Lucia;
- Labianca, Roberto;
- Boneschi, Vinicio;
- Fossati, Silvia;
- Dallavalle, Giuseppe;
- Finzi, Aldo F.;
- Luporini, Gino;
- Brambilla, L;
- Labianca, R;
- Boneschi, V;
- Fossati, S;
- Dallavalle, G;
- Finzi, A F;
- Luporini, G
Publication type:
journal article
A Cisplatinum- Cyclophosphamide Regimen in Advanced Ovarian Cancer: Reporting 5-Year Results.
Published in:
Oncology, 1993, v. 50, n. 2, p. 92, doi. 10.1159/000227155
By:
- Locatelli, M.C.;
- D'Antona, A.;
- Carcione, R.;
- Cesana, B.;
- Dallavalle, G.;
- Vinci, M.;
- Clerici, M.;
- Labianca, R.;
- Pasquinucci, C.;
- Luporini, G.
Publication type:
Article
Epirubicin Treatment of Advanced Breast Carcinoma with the Weekly Low-Dose Regimen.
Published in:
Oncology, 1987, v. 44, n. 1, p. 6, doi. 10.1159/000226434
By:
- Beretta, G.;
- Locatelli, C.;
- Tabiadon, D.;
- Labianca, R.;
- Fraschini, P.;
- Luporini, G.
Publication type:
Article
Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.
Published in:
Colorectal Disease, 2019, v. 21, n. 4, p. 392, doi. 10.1111/codi.14503
By:
- Bastiaenen, V. P.;
- Hovdenak Jakobsen, I.;
- Labianca, R.;
- Martling, A.;
- Morton, D. G.;
- Primrose, J. N.;
- Tanis, P. J.;
- Laurberg, S.
Publication type:
Article
Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey.
Published in:
2008
By:
- Mercadante S;
- Roila F;
- Berretto O;
- Labianca R;
- Casilini S;
- DOMAIN-AIOM study group;
- Mercadante, Sebastiano;
- Roila, Fausto;
- Berretto, Oscar;
- Labianca, Roberto;
- Casilini, Stefania
Publication type:
journal article
A multinational study to measure the value that patients with cancer place on improved emesis control following cisplatin chemotherapy.
Published in:
2001
By:
- Dranitsaris, G.;
- Leung, P.;
- Ciotti, R.;
- Ortega, A.;
- Spinthouri, M.;
- Liaropoulos, L.;
- Labianca, R.;
- Quadri, A.
Publication type:
journal article
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.
Published in:
Advances in Oncology, 2009, v. 4, n. 3, p. 4
By:
- Mandalà, M.;
- Barni, S.;
- Prins, M.;
- Labianca, R.;
- Tondini, C.;
- Russo, L.;
- Milesi, A.;
- Cremonesi, M.;
- Zaccanelli, M.;
- Regonesi, C.;
- Moro, C.;
- Falanga, A.
Publication type:
Article
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.
Published in:
2017
By:
- Ruzzo, A;
- Graziano, F;
- Galli, Fabio;
- Galli, Francesca;
- Rulli, E;
- Lonardi, S;
- Ronzoni, M;
- Massidda, B;
- Zagonel, V;
- Pella, N;
- Mucciarini, C;
- Labianca, R;
- Ionta, M T;
- Bagaloni, I;
- Veltri, E;
- Sozzi, P;
- Barni, S;
- Ricci, V;
- Foltran, L;
- Nicolini, M
Publication type:
journal article
Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies.
Published in:
British Journal of Cancer, 2012, v. 107, n. 4, p. 612, doi. 10.1038/bjc.2012.325
By:
- Mandalà, M;
- Grosso, F;
- Vitalini, C;
- Corradino, I;
- Sanfilippo, R;
- Colombini, S;
- Clerici, M;
- Labianca, R;
- De Pascale, A;
- Marsoni, S
Publication type:
Article
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).
Published in:
British Journal of Cancer, 2012, v. 106, n. 4, p. 658, doi. 10.1038/bjc.2011.606
By:
- Boni, C;
- Tiseo, M;
- Boni, L;
- Baldini, E;
- Recchia, F;
- Barone, C;
- Grossi, F;
- Germano, D;
- Matano, E;
- Marini, G;
- Labianca, R;
- Di Costanzo, F;
- Bagnulo, A;
- Pennucci, C;
- Caroti, C;
- Mencoboni, M;
- Zanelli, F;
- Prochilo, T;
- Cafferata, M A;
- Ardizzoni, A
Publication type:
Article
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).
Published in:
2012
By:
- Boni C;
- Tiseo M;
- Boni L;
- Baldini E;
- Recchia F;
- Barone C;
- Grossi F;
- Germano D;
- Matano E;
- Marini G;
- Labianca R;
- Di Costanzo F;
- Bagnulo A;
- Pennucci C;
- Caroti C;
- Mencoboni M;
- Zanelli F;
- Prochilo T;
- Cafferata MA;
- Ardizzoni A
Publication type:
journal article
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.
Published in:
2011
By:
- Scartozzi, M.;
- Bearzi, I.;
- Mandolesi, A.;
- Giampieri, R.;
- Faloppi, L.;
- Galizia, E.;
- Loupakis, F.;
- Zaniboni, A.;
- Zorzi, F.;
- Biscotti, T.;
- Labianca, R.;
- Falcone, A.;
- Cascinu, S.
Publication type:
journal article
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Published in:
Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 769, doi. 10.1007/s00280-009-0926-8
By:
- Brandes, Alba A.;
- Tosoni, A.;
- Franceschi, E.;
- Blatt, V.;
- Santoro, A.;
- Faedi, M.;
- Amistà, P.;
- Gardiman, M.;
- Labianca, R.;
- Bianchini, C.;
- Ermani, M.;
- Reni, M.
Publication type:
Article
The Role of 5-Fluorouracil (5-FU) Reintroduction with Irinotecan or Oxaliplatin in Truly 5-FU-Refractory Advanced Colorectal Cancer Patients.
Published in:
Oncology, 2005, v. 68, n. 2/3, p. 212, doi. 10.1159/000086776
By:
- Scartozzi, M.;
- Sobrero, A.;
- Gasparini, G.;
- Berardi, R.;
- Catalano, V.;
- Graziano, F.;
- Barni, S.;
- Zaniboni, A.;
- Beretta, G. D.;
- Labianca, R.;
- Cascinu, S.
Publication type:
Article
An Empirical Evaluation of Intelligence-gathering Interrogation Techniques from the United States Army Field Manual.
Published in:
Applied Cognitive Psychology, 2014, v. 28, n. 6, p. 867, doi. 10.1002/acp.3065
By:
- Evans, Jacqueline R.;
- Houston, Kate A.;
- Meissner, Christian A.;
- Ross, Amy B.;
- LaBianca, Julia R.;
- Woestehoff, Skye A.;
- Kleinman, Steven M.
Publication type:
Article
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.
Published in:
British Journal of Cancer, 2008, v. 98, n. 1, p. 71, doi. 10.1038/sj.bjc.6604121
By:
- Cascinu, S.;
- Berardi, R.;
- Salvagni, S.;
- Beretta, G. D.;
- Catalano, V.;
- Pucci, F.;
- Sobrero, A.;
- Tagliaferri, P.;
- Labianca, R.;
- Scartozzi, M.;
- Crocicchio, F.;
- Mari, E.;
- Ardizzoni, A.
Publication type:
Article
Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil.
Published in:
2004
By:
- Guglielmi, A.;
- Barni, S.;
- Zaniboni, A.;
- Pella, N.;
- Belvedere, O.;
- Beretta, G. D.;
- Grossi, F.;
- Frontini, L.;
- Puglisi, F.;
- Labianca, R.;
- Sobrero, A.;
- Gruppo Italiano Studio Carcinomi Apparato Digerente
Publication type:
journal article
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Published in:
British Journal of Cancer, 2004, v. 90, n. 8, p. 1521, doi. 10.1038/sj.bjc.6601752
By:
- Cascinu, S.;
- Scartozzi, M.;
- Labianca, R.;
- Catalano, V.;
- Silva, R. R.;
- Barni, S.;
- Zaniboni, A.;
- Angelo, A. D.;
- Salvagni, S.;
- Martignoni, G.;
- Berardi, R.;
- Graziano, F.;
- Beretta, G. D.;
- Franciosi, V.
Publication type:
Article
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer.
Published in:
British Journal of Cancer, 2003, v. 89, n. 8, p. 1428, doi. 10.1038/sj.bjc.6601280
By:
- Graziano, F.;
- Santini, D.;
- Testa, E.;
- Catalano, V.;
- Beretta, G. D.;
- Mosconi, S.;
- Tonini, G.;
- Lai, V.;
- Labianca, R.;
- Cascinu, S.
Publication type:
Article
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen.
Published in:
2002
By:
- Cascinu, S.;
- Baldelli, A.M.;
- Catalano, V;
- Giordani, P;
- Beretta, G D;
- Silva, R R;
- Gasparini, G;
- Mari, D;
- Maisano, R;
- Salvagni, S;
- Barni, S;
- Labianca, R;
- Frontini, L;
- Curti, C;
- Catalano, G
Publication type:
journal article
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Published in:
British Journal of Cancer, 2001, v. 84, n. 8, p. 1023, doi. 10.1054/bjoc.2001.1732
By:
- Sobrero, A;
- Guglielmi, A;
- Cirillo, M;
- Recaldin, E;
- Frassineti, G L;
- Aschele, C;
- Ravaioli, A;
- Testore, P;
- Caroti, C;
- Gallo, L;
- Pessi, M A;
- Cortesi, E;
- Turci, D;
- Grossi, F;
- Labianca, R
Publication type:
Article
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
Published in:
British Journal of Cancer, 2001, v. 84, n. 4, p. 470, doi. 10.1054/bjoc.2000.1631
By:
- Cascinu, S;
- Graziano, F;
- Barni, S;
- Labianca, R;
- Comella, G;
- Casaretti, R;
- Frontini, L;
- Catalano, V;
- Baldelli, A M;
- Catalano, G
Publication type:
Article
Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer.
Published in:
British Journal of Cancer, 2000, v. 83, n. 5, p. 573, doi. 10.1054/bjoc.2000.1304
By:
- Beretta, G D;
- Michetti, G;
- Belometti, M O;
- Gritti, G;
- Quadri, A;
- Poletti, P;
- Labianca, R
Publication type:
Article
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Published in:
British Journal of Cancer, 1999, v. 80, n. 10, p. 1595, doi. 10.1038/sj.bjc.6690568
By:
- Cascinu, S;
- Silva, R R;
- Barni, S;
- Labianca, R;
- Frontini, L;
- Piazza, E;
- Pancera, G;
- Giordani, P;
- Giuliodori, L;
- Pessi, M A;
- Fusco, V;
- Luporini, G;
- Cellerino, R;
- Catalano, G
Publication type:
Article
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Published in:
British Journal of Cancer, 1999, v. 79, n. 3/4, p. 491, doi. 10.1038/sj.bjc.6690076
By:
- Cascinu, S;
- Frontini, L;
- Comella, G;
- Barni, S;
- Labianca, R;
- Battelli, N;
- Casaretti, R;
- Zonato, S;
- Pirovano, M;
- Catalano, G;
- Cellerino, R
Publication type:
Article
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.
Published in:
2008
By:
- Heinemann V;
- Boeck S;
- Hinke A;
- Labianca R;
- Louvet C;
- Heinemann, Volker;
- Boeck, Stefan;
- Hinke, Axel;
- Labianca, Roberto;
- Louvet, Christophe
Publication type:
journal article

Found: 32